Barbara Klencke, Chief Development Officer at Sierra Oncology, Inc. (SRRA), bought 229,000 shares at $0.45 ($101K) on 2019-08-22, disclosed to the SEC on 2019-08-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.43 | 67,000 | $29K | 28.6% |
| 2 | $0.45 | 54,000 | $24K | 24.1% |
| 3 | $0.44 | 108,000 | $48K | 47.2% |
| Total | $0.44 avg | 229,000 | $101K | 100% |
| Filing → |
| TCRX | BUY | 2023-12-18 | $25K | — | Filing → |
| SRRA | BUY | 2020-08-18 | $113K | — | Filing → |